SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?


To: Xavier who wrote (145)6/12/1998 3:24:00 PM
From: Stanley L. Freedman  Respond to of 413
 
SHould the fact that options can be traded on LVCI have an effect on the price of the stock itself?
A close friend just had the procedure done that changed her sight from 20/800 to 20/25. Going back in July to correct other eye. Not at a LCVI place but an eye center. What do they do- pay a usuage fee for each laser treatment?
Was allowed to watch procedure on T.V. screen. Camera crew there to prepare show for cable in Boston.



To: Xavier who wrote (145)6/12/1998 4:25:00 PM
From: Jim Mac  Read Replies (1) | Respond to of 413
 
Hi Xavier. Glad to see you're still around.

BEAM (and VISX's) legal expenses will drop in Q3, thanks to no more PPP and related litigation. But BEAM will lose more PRK royalties than it's gaining. VISX will gain more PRK royalties than it's losing.

LVCI is the best value now, since they'll likely earn $1.00 (fully-taxed), $1.50 on cash basis in 1999, representing triple-digit EPS growth vs 1998.

I think LCAV is the priciest now. But if it gets closer to $2, I'd buy.

Regards, Jim